Author | Year | Stage | No. of patients | 5-y OS (%) | 5-y LRR rates (%) | ||
---|---|---|---|---|---|---|---|
S | S + PORT | S | S + PORT | ||||
SEER [7] | 2006 | pN2 | 1987 | 20 | 27 | NS | |
ANITA [8] | 2008 | pN2 | 106(observation) | 16.6 | 21.3 | 42.1* | 22.1* |
118(chemotherapy) | 34 | 47.4 | 25.7* | 14.6* | |||
Zou et al. [9] | 2010 | pN2 | 183 | 22.2 | 30.5 | 66 | 27 |
Scotti et al. [10] | 2010 | pN2 | 175 | NS | 44 | 20 | |
Dai et al. [11] | 2011 | IIIA-N2 | 221 | 30.6 | 36.6 | 53 | 36 |
Mantovani et al. [12] | 2013 | pN2 | 66 | NS | 37 | NS | 28 |
Shen et al. [13] | 2014 | IIIA-N2 | 135 | 27.5 | 37.9 | 49.3* | 27.3* |